Funding for a PPIE-Project

  Personalized medicine 2.0 – with the newly funded project „Patient Involvement in Oncology” (PATIO), the LBI Applied Diagnostics aims to create a platform for prostate cancer patients and affected persons that are involved in the illness. The goal of PATIO is to provide both information and support and to create a strong and unique […]

Teatime with Researchers

There are various tools to make science and related topics more approachable to the wider public. In general, science communication formats aim to inform, raise awareness, clarify misconceptions and inspire enthusiasm and excitement. Marie Niederleithinger, one of our institute’s PhD students, is especially interested in the dialog and discussion with her audience.

New FWF Stand-Alone Grant

Congratulations to Assoc. Prof. Dr. Gerda Egger and Dr. Raheleh Sheibani from the Molecular Pathology program line of the LBI:AD! They received a FWF stand-alone grant for the project “The biological role of PSMA for prostate cancer”.  The project focuses on the biological function of prostate specific membrane antigen (PSMA). Go and read more about […]

34th International Austrian Winter Symposium

The 34th International Austrian Winter Symposium took place from the 22nd to the 25th of January 2020 in picturesque Zell am See, Austria. The symposium was organized by the Austrian Society of Nuclear Medicine & Molecular Imaging (OGNMB) and was held under the auspices of our this year’s Congress President Ora Israel from Haifa, Israel. […]

SNMMI TV in Vienna

The LBI Applied Diagnostics was part of a collaboration together with the Division of Nuclear Medicine at the Medical University of Vienna and the Christian Doppler Labor for Applied Metabolomics at the annual meeting of the SNMMI in Anaheim, California in 2019. In preperation for the congress, the team of WebsEdge who are partnering with SNMMI visited […]

Neue Studie im Top-Journal „Journal for ImmunoTherapy of Cancer“

Johannes Längle, Klinischen Abteilung für Allgemeinchirurgie der Universitätsklinik für Chirurgie, belegte zusammen mit WissenschafterInnen des Comprehensive Cancer Center (CCC) der MedUni Wien und des AKH Wien, dass Histon-Deazetylase-Inhibitoren (HDACi) in Kombination mit dem Wirkstoff Trastuzumab die körpereigene Immunabwehr in Form der Phagozytose („Auffressen“) von Brustkrebszellen positiv verstärken. Die Studie wurde unter anderem im Rahmen des […]

Awarded DOC fellowship

We are very proud to announce that Loan Tran, PhD student of the program line Molecular Pathology, was awarded a DOC grant by the Austrian Academy of Sciences (ÖAW) to fund the continuation of her PhD project’s research on colorectal cancer.

MIC Festival 2019

The MIC Festival of the Medical Imaging Cluster (MIC) of the Medical University of Vienna took place last week on June, 6th 2019. This year’s motto was Digital Revolution in Medical Imaging, highlighting the ever growing importance of big data, digitalization and computational analysis and their translation to clinical routine and research. Just as last […]

New Chelator for Radiolabelling

In a joint research effort supported by the Swiss National Science Foundation, the groups of Prof. Gilles Gasser (Chimie ParisTech) and Prof. Thomas Mindt (LBIAD) have developed a new chelator for the radiolabelling of antibodies and other molecules with the PET radiometal zirconium-89.[1] The new chelator, termed DFO*, provides 89Zr-complexes that are extraordinarily stable in […]

2nd Scientific Advisory Board Meeting

A bit over one year after meeting with our Scientific Advisory Board (SAB) for the first time, our LBI:AD had their second meeting with the SAB last week on the 13th of May 2019. The SAB consists of five internationally renowned experts, which were again invited to review our institute’s research, to evaluate our progress […]